Cronos Group Inc. stock falls Thursday, underperforms market

Cronos Group Inc. (CRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Cronos Group Reports 2026 Second Quarter Results Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis Delivered record net revenue in Can

Activist short seller Andrew Left, founder of Citron Research, was convicted in Los Angeles federal court of securities fraud for allegedly manipulating stock prices using his social-media following. A jury found him guilty on 1 scheme count and 12 securities-fraud counts; prosecutors said he profited about $20 million. He plans to appeal and faces sentencing Aug. 31, with up to 25 years on the lead count.

Hims & Hers Health (HIMS) rose 7.36% to $30.13 on news of potential peptide regulation changes. The company plans to offer peptides by 2026. Analysts have mixed views, with Citi targeting $25 (17% downside) and Truist at $32. Q3 earnings on Nov 9, 2026, will be key.

Arista Networks (ANET) shares rose 2% to $215.60 after introducing an open Ethernet portfolio for AI networking, aiming to reduce bottlenecks and increase hardware choice. The new architecture connects up to 1,024 accelerators across racks, with plans to increase bandwidth and reduce data-center footprint. The company's shares trade 28.06% above the GF Value estimate, but no orders or pricing details were provided.

Palantir (PLTR) shares rose 2.5% after Barclays initiated coverage with an Overweight rating and $265 price target, citing growth prospects and profitability. The company develops software for data analysis and decision-making. Investors are evaluating Palantir's growth potential and valuation.

Apple shares fell around 1.7% on Friday after Nikkei Asia reported the company cut iPhone 18 Pro and Pro Max component orders by 15-20% due to softer-than-expected demand. The decline occurred despite broader market gains, with investors reacting to potential weaker sales of Apple's newest premium models.